MONTREAL, Feb. 10, 2026 /CNW/ - AI4Eyes today announced the expansion of its Board of Directors as the company enters its next phase of strategic and operational growth. Following the appointment of Dr. Tara Akhavan as Chief Executive Officer in February 2025, AI4Eyes expanded its Board in Q4 2025 to include two independent industry experts, strengthening governance and strategic oversight as the company advances toward regulated commercialization and broader market adoption.
The Board of Directors includes Daniel Hofmann, BSc MBA, Dr. Tara Akhavan, PhD, Dr. John Hovanesian, and Ken McCracken CPA. Collectively, they bring deep experience across healthcare, medical technology, artificial intelligence, mergers and acquisitions, and commercialization. The Board will work closely with the executive team to guide strategy, governance, and execution as AI4Eyes advances its clinical and regulatory roadmap.